- Home
- ATLN vs ATAI Comparison
ATLN vs ATAI Comparison
Compare ATLN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLN
- ATAI
- Stock Information
- Founded
- ATLN N/A
- ATAI 2018
- Country
- ATLN
- ATAI Germany
- Employees
- ATLN 7
- ATAI N/A
- Industry
- ATLN
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ATLN
- ATAI Health Care
- Exchange
- ATLN NYSE
- ATAI Nasdaq
- Market Cap
- ATLN 248.2M
- ATAI 222.3M
- IPO Year
- ATLN N/A
- ATAI 2021
- Fundamental
- Price
- ATLN $5.65
- ATAI $1.46
- Analyst Decision
- ATLN
- ATAI Strong Buy
- Analyst Count
- ATLN 0
- ATAI 4
- Target Price
- ATLN N/A
- ATAI $9.00
- AVG Volume (30 Days)
- ATLN N/A
- ATAI 1.8M
- Earning Date
- ATLN N/A
- ATAI 11-13-2024
- Dividend Yield
- ATLN N/A
- ATAI N/A
- EPS Growth
- ATLN N/A
- ATAI N/A
- EPS
- ATLN N/A
- ATAI N/A
- Revenue
- ATLN N/A
- ATAI $331,000.00
- Revenue This Year
- ATLN N/A
- ATAI $80.07
- Revenue Next Year
- ATLN N/A
- ATAI N/A
- P/E Ratio
- ATLN N/A
- ATAI N/A
- Revenue Growth
- ATLN N/A
- ATAI N/A
- 52 Week Low
- ATLN N/A
- ATAI $1.03
- 52 Week High
- ATLN N/A
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- ATLN N/A
- ATAI 50.37
- Support Level
- ATLN N/A
- ATAI $1.36
- Resistance Level
- ATLN N/A
- ATAI $1.50
- Average True Range (ATR)
- ATLN 0.00
- ATAI 0.15
- MACD
- ATLN 0.00
- ATAI -0.01
- Stochastic Oscillator
- ATLN 0.00
- ATAI 35.71
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.